Request Trial

Pharma news

Reset all filters
Geography
Company
Refine search
US govt backs Hikma over ‘skinny label’ rules
Americas
US govt backs Hikma over ‘skinny label’ rules
Solicitor General urges the US Supreme Court to hear an appeal in its dispute, arguing that a ruling threatens the future of skinny labelling and the availability of lower-cost generics.   9 December 2025
New IP guidance promises to transform the NHS. Will it deliver?
Europe
New IP guidance promises to transform the NHS. Will it deliver?
The move could unlock billions in life sciences collaborations and position the UK to rival the US and China. But turning a famously conservative, patient-safety-first institution into a commercially savvy innovation hub will be no small feat.   2 December 2025
WATCH: Reshaping the rules—recent IP reforms and their impact on Brazil’s pharma market
Americas
WATCH: Reshaping the rules—recent IP reforms and their impact on Brazil’s pharma market
Brazil’s pharmaceutical IP landscape is shifting fast, and Juliana Neves of Licks unpacks how new reforms, guidelines, and rulings are resetting the strategic ground rules for innovators.   2 December 2025
Europe
EU Pharma Package hits the final stretch—but can negotiators agree?
With EU trilogues deadlocked over the package, the future of drug exclusivities and access-linked obligations hangs in the balance. Jackie Mulryne and Paul Ranson of Morgan Lewis pinpoint the flashpoints to watch as negotiators push for a year-end deal.   28 November 2025
Americas
Squires affirms USPTO’s stance on AI with revised guidance
Director Squires rescinds previous guidelines and clarifies that there is no separate, modified inventorship standard for AI-assisted inventions.   27 November 2025
Pharma
The clinical trial dilemma: Navigating European practice
Clinical trials create a patent paradox. With EPO case law rapidly reshaping the 'expectation of success' test—most recently T136/24—the line between innovation and obviousness is blurred. Amanda Simons of J A Kemp offers drafting strategies to secure protection for your downstream innovations.   27 November 2025
Americas
Novartis counsel on managing patents at a $50bn company
Balancing tight budgets while keeping up with fast-changing biosimilar rules is all in a day’s work for Novartis’s R&D IP team, but how do they stay on top of it all?   26 November 2025
Europe
What people talked about at London Life Sciences Week
The week exposed fractures in the UK's industry—but also unexpected reasons for optimism. Five themes dominated conversations about the direction of the country's life sciences sector.   21 November 2025
Europe
NHS updates outdated IP rules in bid to revive UK life sciences
The country’s public health service has replaced its IP framework with a nine-step plan, as the government tries to reposition the UK as a global life sciences leader.   20 November 2025
Americas
MSD wins full sweep in world’s best-selling drug clash
A PTAB dispute over $29.5bn drug reaches a dramatic conclusion, at a critical time ahead of the drug's US patent expiration.   20 November 2025